Specifically, KANK2 mRNA levels were significantly lower in cancers such as BLCA, BRCA, COAD, KICH, KIRP, LUAD, LUSC, PRAD, READ, and UCEC, whereas higher levels were detected in CHOL, GBM, HNSC, KIRC, LIHC, and PAAD. Here, KANK2 is linked to cancer.